Skip to content. | Skip to navigation

Sections
Personal tools
You are here: Home > Project Area > MARMED

MARMED

Nowadays, marine resources management is not performed in a sustainable way, with high value potential by-products and residues currently being discarded. In particular, by-products such as fish bones can be used to obtain calcium phosphates and collagen; calcium phosphates and chitin/chitosan can be obtained from crustacean exoskeletons and mollusk endoskeletons; and from residues of algal blooms different polysaccharides can be extracted. Once extracted and purified, these biopolymers and ceramics can be used in different biomedical areas, such as biomaterials for human tissue regeneration and/or for the release of bioactive compounds.

The inspiration for the MARMED project emerges from a common need felt by the partners in the Member States involved, to achieve better exploitation and use of natural derived resources.

MARMED project’s objective is working on the recovery of by-products and residues for biomedical applications, in close cooperation with industries which will evaluate the market potential of these applications to be developped or studied.

In this context, the consortium is developing work on the recovery of these by-products and residues, a type of recovery that is considerably innovative and with high potential for industrial application.

MARMED’s ambition is to allow for the continuous, sustainable and economically viable exploration of the natural resources from coastal regions, fluvial basins and aquaculture by adding value to many of the constituents of these resources. It aims to develop environmentally friendly technologies for the conversion of residues into products with industrial application, through the establishment of simple, efficient and economically viable methods to extract and purify the substances found in marine and fluvial flora/fauna and aquaculture.

The recovery of the components extracted by biochemical and biotechnological methods and the development of innovative products for applications in the biomedical field, represent a step forward since, instead of just showing what can be done, it already aspires to obtain market-driven products.

More information

Document Actions
Log in


Forgot your password?
 
European Union